FindTrial
Sign In

Construction of a technical system for isolation and purification of NK cells from whole blood

Construction of a technical system for isolation and purification of NK cells from whole blood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120916
Enrollment
Unknown
Registered
2026-03-23
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Female blood donation group:None
male blood donation group:None

Sponsors

QingDao Blood Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy blood donors who donate 400 milliliters of whole blood.

Exclusion criteria

Exclusion criteria: First-time blood donors, those with infectious diseases, and donors of 300 mL whole blood are excluded.

Design outcomes

Primary

MeasureTime frame
NK cell purity (CD3-CD56+ cell ratio) ;—

Countries

China

Contacts

Public ContactAn Run

QingDao Blood Center

anrun@126.com+86 532 8570 7057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026